IRIS
ORLANDI, ESTER
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.365
AS - Asia 1.211
EU - Europa 772
SA - Sud America 178
AF - Africa 35
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.564
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.291
SG - Singapore 393
CN - Cina 342
HK - Hong Kong 295
RU - Federazione Russa 247
BR - Brasile 146
DE - Germania 136
IT - Italia 83
GB - Regno Unito 75
VN - Vietnam 69
IE - Irlanda 65
FI - Finlandia 39
MX - Messico 36
CA - Canada 28
FR - Francia 25
IN - India 22
JP - Giappone 22
PL - Polonia 21
AT - Austria 16
SE - Svezia 16
ZA - Sudafrica 16
BD - Bangladesh 15
AR - Argentina 13
BE - Belgio 13
ES - Italia 8
IQ - Iraq 7
TR - Turchia 6
CO - Colombia 5
NL - Olanda 5
EC - Ecuador 4
ID - Indonesia 4
IL - Israele 4
SA - Arabia Saudita 4
UZ - Uzbekistan 4
VE - Venezuela 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
EG - Egitto 3
LV - Lettonia 3
MA - Marocco 3
PK - Pakistan 3
PY - Paraguay 3
SN - Senegal 3
TN - Tunisia 3
AU - Australia 2
BH - Bahrain 2
DZ - Algeria 2
ET - Etiopia 2
HN - Honduras 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
LT - Lituania 2
NO - Norvegia 2
NP - Nepal 2
PA - Panama 2
QA - Qatar 2
UA - Ucraina 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GF - Guiana Francese 1
GP - Guadalupe 1
GR - Grecia 1
KE - Kenya 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 3.564
Salva come PNG Salva come JPEG
Città #
Dallas 494
Hong Kong 294
Singapore 147
Ashburn 101
Beijing 97
Dublin 65
Redondo Beach 65
Los Angeles 62
Munich 50
Moscow 44
Falkenstein 40
Chandler 35
Buffalo 28
Mexico City 28
New York 28
Pavia 25
Shanghai 24
Ho Chi Minh City 23
Santa Clara 21
Helsinki 20
Hanoi 19
Montreal 19
Tokyo 19
Warsaw 19
Boardman 18
São Paulo 16
Turku 16
Secaucus 15
Brooklyn 14
Brussels 13
Changsha 13
Johannesburg 13
Stockholm 13
Atlanta 11
Denver 11
Frankfurt am Main 11
Nuremberg 11
Orem 11
Boston 10
Chicago 10
London 10
Milan 10
Seattle 10
Council Bluffs 9
Princeton 9
Düsseldorf 8
Lawrence 8
Belo Horizonte 7
Dhaka 7
Medford 7
Phoenix 7
Ann Arbor 6
Charlotte 6
Chennai 6
Elk Grove Village 6
Guangzhou 6
Nanjing 6
Poplar 6
Wilmington 6
Ankara 5
Buccinasco 5
Florence 5
Haiphong 5
Jacksonville 5
Manchester 5
San Francisco 5
Vienna 5
Hyderabad 4
Hải Dương 4
Nanchang 4
Rio de Janeiro 4
Riyadh 4
Rozzano 4
Tashkent 4
Tianjin 4
Wuhan 4
Yiwu 4
Aubergenville 3
Baku 3
Brasília 3
Chiba 3
Da Nang 3
Dakar 3
Houston 3
Lauterbourg 3
Lucknow 3
Pittsburgh 3
Porto Alegre 3
Querétaro 3
Riga 3
St Louis 3
The Dalles 3
Turin 3
Woodbridge 3
Addis Ababa 2
Amman 2
Amsterdam 2
Annapolis 2
Aparecida de Goiânia 2
Baghdad 2
Totale 2.256
Salva come PNG Salva come JPEG
Nome #
Prognostic Value of Metabolic Parameters by 18 F-FDG PET/CT in Nasopharyngeal Cancer (NPC) in Non-Endemic Area 287
Intravoxel incoherent motion as a tool to detect early microstructural changes in meningiomas treated with proton therapy 85
Cancer Rehabilitation and Physical Activity: the "Oncology in Motion" Project 77
Is motherhood still possible after pelvic carbon ion radiotherapy? A promising combined fertility-preservation approach 74
Contouring of the Pharyngeal Superior Constrictor Muscle (PSCM). A cooperative study of the Italian Association of Radiation Oncology (AIRO) Head and Neck Group 70
Radiomics and dosiomics for predicting local control after carbon-ion radiotherapy in skull-base chordoma 70
To a new normal in radiation oncology: looking back and planning forward 66
Pancreatic cancer: Does a short course of carbon ion radiotherapy worth during COVID-19 outbreak? 62
Dosimetric and Clinical Risk Factors for the Development of Maxillary Osteoradionecrosis in Adenoid Cystic Carcinoma (ACC) Patients Treated With Carbon Ion Radiotherapy 62
A monocentric, open-label randomized standard-of-care controlled study of XONRID®, a medical device for the prevention and treatment of radiation-induced dermatitis in breast and head and neck cancer patients 59
Head and Neck Cancer (HNC) Prehabilitation: Advantages and Limitations 57
Role of diffusion-weighted MRI in recurrent rectal cancer treated with carbon ion radiotherapy 56
Immune checkpoint inhibitors and Carbon iON radiotherapy In solid Cancers with stable disease (ICONIC) 54
Using the photon isoeffective dose formalism to compare and combine BNCT and CIRT in a head and neck tumour 51
Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review 50
Cardiac conduction system exposure with modern radiotherapy techniques for mediastinal Hodgkin lymphoma irradiation 49
Biological Rationale and Clinical Evidence of Carbon Ion Radiation Therapy for Adenoid Cystic Carcinoma: A Narrative Review 47
Charged particle radiotherapy for thyroid cancer. A systematic review 46
A phase II trial of induction chemotherapy (IC), photon-, proton- and carbon ion-based radiotherapy (RT) integration in locally advanced inoperable sinonasal epithelial tumors patients (pts) 46
Unlocking the Potential Role of Decellularized Biological Scaffolds as a 3D Radiobiological Model for Low- and High-LET Irradiation 45
Ablative Radiotherapy (ART) for Locally Advanced Pancreatic Cancer (LAPC): Toward a New Paradigm? 45
Evaluation of endocrinological sequelae following particle therapy performed on anterior skull base lesions in the adult population 43
NR4A3 fusion molecular profile change pathological diagnosis? A case report 43
A Patient Selection Approach Based on NTCP Models and DVH Parameters for Definitive Proton Therapy in Locally Advanced Sinonasal Cancer Patients 42
Preoperative chemo-CIRT in Re/BRe pancreatic cancer: Insights from a multicenter prospective phase II clinical study (NCT03822936) 41
The Interplay between Age and Viral Status in EBV-Related Nasopharyngeal and HPV-Related Oropharyngeal Carcinoma Patients 40
Activity of platinum and cetuximab in cutaneous squamous cell cancer not amenable to curative treatment 39
Baseline MRI-radiomics can predict overall survival in non endemic nasopharyngeal cancer patients 39
A Dosiomics Analysis Based on Linear Energy Transfer and Biological Dose Maps to Predict Local Recurrence in Sacral Chordomas after Carbon-Ion Radiotherapy 38
AIRO GORTEC consensus on postoperative radiotherapy (PORT) in low-intermediate risk early stages oral squamous cell cancers (OSCC) 38
A year of pandemic for European particle radiotherapy: A survey on behalf of EPTN working group 37
CISPLATIN DOSE INTENSITY CORRELATES WITH OUTCOME IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA RECEIVING CONCURRENT CISPLATIN BASED CHEMORADIATION: A MULTI-INSTITUTIONAL EXPERIENCE 35
Are there any dosimetric predictors of acute toxicity during RT for NPC that can be modulated by genetic risk factors? 35
Granulosa cell tumors (GCTs) of the ovary: What is the role of radiotherapy? 35
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 35
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 34
Role of IMRT/VMAT-Based Dose and Volume Parameters in Predicting 5-Year Local Control and Survival in Nasopharyngeal Cancer Patients 34
Managing locally advanced adenoid cystic carcinoma of the head and neck during the COVID-19 pandemic crisis: Is this the right time for particle therapy? 33
Implementing a virtual multidisciplinary clinical case discussion to manage rare and complex head and neck cancers: an expert-defined protocol proposal from the Italian Association of Head and Neck Oncology (AIOCC) 33
Sexual Health Dysfunction After Radiotherapy for Gynecological Cancer: Role of Physical Rehabilitation Including Pelvic Floor Muscle Training 33
Baseline MRI-Radiomics Can Predict Overall Survival in Non-Endemic EBV-Related Nasopharyngeal Carcinoma Patients 33
Modelling Radiation-Induced Salivary Dysfunction during IMRT and Chemotherapy for Nasopharyngeal Cancer Patients 32
Exploring the role of neutrophil-to-lymphocyte ratio and blood chemistry in head and neck adenoid cystic carcinomas treated with carbon ion radiotherapy 32
Locally advanced epithelial sinonasal tumors: The impact of multimodal approach 32
The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers 32
Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients 32
A retrospective multicenter Italian analysis of the effect of longer vismodegib intake in 68 basal cell carcinoma patients who achieved clinical complete remission 32
Carbon ion radiotherapy in gynaecological oncology: where we are and where we are headed 32
Ovarian Cancer Radiosensitivity: What Have We Understood So Far? 31
The Role of Neutrophil-Lymphocytes Ratio in the Prognosis of CIN2+ Recurrence after Excisional Treatment 30
How can we address the challenge of distant metastases in HNSCC prognosis? 29
Current management and future challenges in salivary glands cancer 29
Patients with adenoid cystic carcinomas of the salivary glands treated with lenvatinib: Activity and quality of life 28
Neutron brachytherapy in the modern era: Indications and evidence 28
An international approach to estimating the indications and number of eligible patients for carbon ion radiation therapy (CIRT) in Australia 28
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report 27
Multidisciplinary Management of Radiation-Induced Salivary Gland Carcinomas in the Modern Radiotherapy Era 27
Radiation Therapy for Gestational Trophoblastic Neoplasia: Forward-Looking Lessons Learnt 26
Tumor Biomarkers for the Prediction of Distant Metastasis in Head and Neck Squamous Cell Carcinoma 26
Prognostic nomogram in patients with metastatic adenoid cystic carcinoma of the salivary glands 25
The Role of Carbon Ion Therapy in the Changing Oncology Landscape—A Narrative Review of the Literature and the Decade of Carbon Ion Experience at the Italian National Center for Oncological Hadrontherapy 25
Resection of the internal carotid artery in selected patients affected by cancer of the skull base 25
A snapshot on radiotherapy for head and neck cancer patients during the COVID-19 pandemic: a survey of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group 25
Moderately accelerated intensity-modulated radiation therapy using simultaneous integrated boost: Practical reasons or evidence-based choice? A critical appraisal of literature 23
The SINTART 1 study: A phase II trial of induction chemotherapy (IC), surgery, photon-, proton-and carbon ion-based radiotherapy (RT) integration in locally advanced operable sinonasal epithelial tumors patients (pts) 23
Toxicity of carbon ion radiotherapy and immune checkpoint inhibitors in advanced melanoma 23
Clinical outcome of stereotactic body radiotherapy for lung-only oligometastatic head and neck squamous cell carcinoma: Is the deferral of systemic therapy a potential goal? 22
Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up 22
The first real-world study on the role of carbon ion radiotherapy for oligo-metastatic, persistent, or recurrent (MPR) ovarian/fallopian tube cancer 22
Patterns of Failure after Intensity Modulated Radiation Therapy (IMRT) and Chemotherapy for Patients with Nasopharyngeal Carcinoma 22
Towards a European prospective data registry for particle therapy 21
Metastatic salivary gland carcinoma: A role for stereotactic body radiation therapy? A study of AIRO-Head and Neck working group 21
Radiotherapy and Medical Treatment 21
Curative carbon ion radiotherapy in a head and neck mucosal melanoma series: Facing the future within multidisciplinarity 21
The MUSES∗: a prognostic study on 1360 patients with sinonasal cancer undergoing endoscopic surgery-based treatment 20
Role of pretreatment 18F-FDG PET/CT parameters in predicting outcome of non-endemic EBV DNA-related nasopharyngeal cancer (NPC) patients treated with IMRT and chemotherapy 20
INDUCTION CHEMOTHERAPY WITHIN A MULTIMODALITYREATMENT OF NASAL CAVITY AND ETHMOID SINUS MALIGNANT EPITHELIAL TUMOURS: REPORT OF AN HOMOGENEOUS SERIES OF PATIENTS 20
Salivary Gland. Photon beam and particle radiotherapy: Present and future 20
Quality of life and financial toxicity after (chemo)radiation therapy in head and neck cancer: are there any sex- or gender-related differences? 19
Local therapies for liver metastases of rare head and neck cancers: a monoinstitutional case series 19
How LEM-based RBE and dose-averaged LET affected clinical outcomes of sacral chordoma patients treated with carbon ion radiotherapy: RBE and LET in carbon ion therapy for sacral chordoma 18
Dysphagia in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus 18
Proton Radiation Therapy for Nasopharyngeal Cancer Patients: Dosimetric and NTCP Evaluation Supporting Clinical Decision 18
Clinical Insight on Proton Therapy for Paediatric Rhabdomyosarcoma 18
Quality of life changes over time and predictors in a large head and neck patients’ cohort: secondary analysis from an Italian multi-center longitudinal, prospective, observational study—a study of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) head and neck working group 18
Current practice in proton therapy delivery in adult cancer patients across Europe 17
Radiobiological basis and clinical results of the simultaneous integrated boost (SIB) in intensity modulated radiotherapy (IMRT) for head and neck cancer: A review 17
Treatment of loco-regional recurrence of nasopharyngeal carcinoma in a non-endemic area: oncologic outcomes, morbidity, and proposal of a prognostic nomogram 17
Repeatability and reproducibility of MRI‐radiomic features: A phantom experiment on a 1.5 T scanner 17
Particle Reirradiation of Malignant Epithelial and Neuroectodermal Sinonasal Tumors: A Case Series from CNAO 17
Pragmatic, Prospective Comparative Effectiveness Trial of Carbon Ion Therapy, Surgery, and Proton Therapy for the Management of Pelvic Sarcomas (Soft Tissue/Bone) Involving the Bone: The PROSPER Study Rationale and Design 17
The SINTART 2 Study. A phase II non-randomised controlled trial of induction chemotherapy, photon-, proton- and carbon-ion-based radiotherapy integration in patients with locally advanced unresectable sinonasal tumours 17
Mutational profile of epithelial, non-glandular sinonasal cancers into 2 prospective clinical trials 16
Gene-expression profiles of primary and metastatic lesions in head and neck squamous cell carcinoma 16
Systematic review for deep inspiration breath hold in proton therapy for mediastinal lymphoma: A PTCOG Lymphoma Subcommittee report and recommendations 16
Nasopharyngeal cancer: the impact of guidelines and teaching on radiation target volume delineation 16
Comprehensive insights on the underlying potential and advantage of proton therapy over intensity-modulated photon radiation therapy as highlighted in a wide real world data analysis 16
Mixed-Beam Approach for High-Risk Prostate Cancer Carbon-Ion Boost Followed by Photon Intensity-Modulated Radiotherapy: Preliminary Results of Phase II Trial AIRC-IG-14300 16
The role of multiple anatomical scenarios in plan optimization for carbon ion radiotherapy of pancreatic cancer: Inter-fraction robustness in CIRT for pancreatic cancer 16
LOCALLY ADVANCED NASAL CAVITY AND ETHMOID CARCINOMA: INDUCTION CHEMOTHERAPY FOLLOWED BY MULTIMODAL TREATMENT IN A MONOINSTITUTIONAL SERIES OF PATIENTS 15
Totale 3.526
Salva come PNG Salva come JPEG
Categoria #
all - tutte 17.588
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.588
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20217 0 0 0 0 0 0 1 4 0 1 1 0
2021/202243 0 1 0 3 0 2 1 3 4 3 4 22
2022/2023153 16 9 4 5 4 13 15 4 67 1 9 6
2023/2024107 8 9 3 8 7 14 6 16 3 2 19 12
2024/20251.345 11 25 10 10 10 103 211 116 318 56 107 368
2025/20262.009 265 555 287 409 387 106 0 0 0 0 0 0
Totale 3.686